Brief: 3Sbio Says First Patient Enrolled In Trial Of Phase III Clinical Study Of Recombinant Human Thrombopoietin Injection
22/05/2023 10:25
May 22 (Reuters) - 3SBio Inc 1530.HK :
* 3SBIO - FIRST PATIENT ENROLLED IN TRIAL OF PHASE III
CLINICAL
STUDY OF 3SBIO'S RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO)
INJECTION (TPIAO)
Further company coverage: 1530.HK
((Reuters.Briefs@thomsonreuters.com;))